Drugs that contain Budesonide; Formoterol Fumarate Dihydrate

1. List of Symbicort drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7967011

(Pediatric)

ASTRAZENECA Inhalation device
Feb, 2022

(11 months ago)

US7759328 ASTRAZENECA Composition for inhalation
Jan, 2023

(a day from now)

US8575137 ASTRAZENECA Composition for inhalation
Jan, 2023

(a day from now)

US10166247 ASTRAZENECA Composition for inhalation
Jan, 2023

(a day from now)

US8143239 ASTRAZENECA Composition for inhalation
Jan, 2023

(a day from now)

US11311558 ASTRAZENECA Composition for inhalation
Jan, 2023

(a day from now)

US8575137

(Pediatric)

ASTRAZENECA Composition for inhalation
Jul, 2023

(5 months from now)

US7759328

(Pediatric)

ASTRAZENECA Composition for inhalation
Jul, 2023

(5 months from now)

US11311558

(Pediatric)

ASTRAZENECA Composition for inhalation
Jul, 2023

(5 months from now)

US8143239

(Pediatric)

ASTRAZENECA Composition for inhalation
Jul, 2023

(5 months from now)

US10166247

(Pediatric)

ASTRAZENECA Composition for inhalation
Jul, 2023

(5 months from now)

US8875699 ASTRAZENECA Inhaler cap strap
Nov, 2024

(1 year, 9 months from now)

US8875699

(Pediatric)

ASTRAZENECA Inhaler cap strap
May, 2025

(2 years from now)

US7587988 ASTRAZENECA Inhaler device counter
Apr, 2026

(3 years from now)

US7587988

(Pediatric)

ASTRAZENECA Inhaler device counter
Oct, 2026

(3 years from now)

US8387615 ASTRAZENECA Inhaler cap strap
Mar, 2027

(4 years from now)

US8387615

(Pediatric)

ASTRAZENECA Inhaler cap strap
Sep, 2027

(4 years from now)

US8528545 ASTRAZENECA Inhaler device that reduces the risk for miscounting a dosage
Oct, 2028

(5 years from now)

US8616196 ASTRAZENECA Inhalation device and a method for assembling said inhalation device
Apr, 2029

(6 years from now)

US8528545

(Pediatric)

ASTRAZENECA Inhaler device that reduces the risk for miscounting a dosage
Apr, 2029

(6 years from now)

US8616196

(Pediatric)

ASTRAZENECA Inhalation device and a method for assembling said inhalation device
Oct, 2029

(6 years from now)

Market Authorisation Date: 21 July, 2006

Treatment: Use for the treatment of asthma in patients 6 years of age and older; Use for reducing exacerbations of chronic obstructive pulmonary disease; Use for maintenance treatment of chronic obstructive pulmonary disease

Dosage: AEROSOL, METERED;INHALATION

How can I launch a generic of SYMBICORT before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic